Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Here is a Kaiser Health News/NPR story on our research on healthcare cost conversations in doctor’s offices. Talking about money is never easy. But when doctors are reluctant to talk about medical costs, patients’ health can be undermined. A study published Monday in the journal Health Affairs explores the opportunities that are often missed in the exam room. Patients…
See my local TV interview in the early hours after the SCOTUS decision on the individual mandate
And see some of my quotes from local and national reporters at the links below:
The Herald Sun
Triangle Business Journal
Washington Post
Some people look at the figure below, and say that too few insurance companies have too much of the market for Medicare Advantage (a program that allows Medicare recipients to get private coverage). But I look at it and think it looks like a pretty robust market: What do you think?
“Contracts With Patients in Clinical Practice” – The Lancet
Usually it costs money to get an MRI. But sometimes, in order to save money, insurance companies pay patients to seek less expensive medical care providers. Here is an excellent news report on the topic from The News & Observer: North Carolina’s largest health insurer is proposing a solution to control runaway health care costs:…
My article with Peter Bach of Memorial Sloan Kettering continues to generate debate. The two of us argues that copay assistance programs from pharmaceutical companies help specific patients in the short run, but make it easier for drug companies to demand high prices for their products. Here is one take on the topic, spurred on…